Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 18, 2021
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of October 17, 2021
Tip Sheet: New MacArthur ‘genius,’ returning to school during COVID-19 and the science of race and racism
Summaries of recent Fred Hutch research findings and other news
Scientists boost immune function in mice by mimicking natural renewal processes
New study identifies molecular players in ‘dead man’s switch’ that triggers key immune organ’s regeneration after damage
Q&A: Returning to school, post-transplant
As schools reopen for in-person learning, what should bone marrow transplant recipients do?
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations
Summaries of recent Fred Hutch research findings and other news
How studies of coronavirus immunity can inform better vaccines, treatments
Scientists look for broad-acting antibodies that could protect against new variants of SARS-CoV-2 — and maybe a future SARS-3
Cancer patients and the COVID-19 vaccines
Clinicians, cancer patients and coronavirus researchers weigh in on vaccination safety, timing, allergy concerns and more
A short primer on coronavirus biology
Hutch virologist explains viral pandemics and COVID-19
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Insights from infants could inform HIV vaccine design
Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV
mRNA: the future of vaccines?
The Gottardo Laboratory, Vaccine and Infectious Disease Division
Teacher, mom — and living immunotherapy proof of principle
Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.
Using a virus to teach the immune system to kill cancer
‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma
Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated
New study looks at how persistent organic pollutants affect vaccines
New Fred Hutch study looks at whether persistent organic pollutants can undercut vaccines
6 questions in cancer immunotherapy
From cancer vaccines to engineered T cells, experts weigh in on the big unknowns
Building a better protein in the hope of better therapies
Researchers design and create donut-shaped proteins from scratch
HPV vaccines work – so why do so few states require them?
Only Virginia, Washington, D.C., and soon, Rhode Island, include the cancer-preventing vaccine as a school requirement
HIV vaccine: Could a few special cells help protect millions of people?
New analysis finds rare immune cells linked to HIV vaccine’s effectiveness